AstraZeneca is paying $160 million for FibroGen’s China business, giving the U.K.-based Big Pharma the regional rights to oral anemia drug roxadustat. The two companies' relationship around ...
The premium audio specialist is now shipping the SMZ16-PRE 16x16, the latest addition to the SMZ-Series. The SMZ16-PRE ...
FOXF Fox Factory Holding Corp.
Up to 20% Your First Order Exclusive 1800 Contacts Discount ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback